Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Microarray Analysis of Gene Expression in Prostate Tissues
- Status
- COMPLETED
- Phase
- N/A
A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trilostane for Androgen-Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE3
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3
Registry and Database Lap Prostatectomy
- Status
- COMPLETED
- Phase
- N/A